Total Payments
$436,969
2024 Payments
$53,846
Companies
46
Transactions
1,063
Medicare Patients
5,370
Medicare Billing
$437,180
Payment Breakdown by Category
Other$274,437 (62.8%)
Consulting$114,805 (26.3%)
Travel$27,053 (6.2%)
Food & Beverage$20,577 (4.7%)
Education$99.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $274,437 | 96 | 62.8% |
| Consulting Fee | $114,805 | 41 | 26.3% |
| Travel and Lodging | $27,053 | 137 | 6.2% |
| Food and Beverage | $20,577 | 788 | 4.7% |
| Education | $99.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $230,154 | 308 | $0 (2022) |
| Galderma Laboratories, L.P. | $99,718 | 150 | $0 (2024) |
| ABBVIE INC. | $96,013 | 204 | $0 (2024) |
| Aclaris Therapeutics, Inc. | $2,011 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,140 | 48 | $0 (2024) |
| GENZYME CORPORATION | $1,135 | 31 | $0 (2024) |
| PFIZER INC. | $699.19 | 44 | $0 (2024) |
| LEO Pharma Inc. | $661.57 | 46 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $645.81 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $432.58 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,846 | 161 | ABBVIE INC. ($37,375) |
| 2023 | $67,696 | 111 | ABBVIE INC. ($57,517) |
| 2022 | $114,382 | 172 | Allergan, Inc. ($71,686) |
| 2021 | $58,508 | 107 | Allergan, Inc. ($39,618) |
| 2020 | $7,455 | 43 | Galderma Laboratories, L.P. ($6,733) |
| 2019 | $14,333 | 115 | Galderma Laboratories, L.P. ($9,145) |
| 2018 | $25,175 | 141 | Allergan Inc. ($22,809) |
| 2017 | $95,575 | 213 | Allergan Inc. ($94,085) |
All Payment Transactions
1,063 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Inflammation & Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $38.06 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Immunology | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.13 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.99 | General |
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.84 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,461 | 2,129 | $248,062 | $122,369 |
| 2022 | 11 | 1,208 | 1,852 | $200,949 | $96,691 |
| 2021 | 16 | 1,491 | 6,820 | $251,417 | $126,446 |
| 2020 | 14 | 1,210 | 5,745 | $189,058 | $91,674 |
Total Patients
5,370
Total Services
16,546
Medicare Billing
$437,180
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 420 | 645 | $86,840 | $42,775 | 49.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 246 | 306 | $48,764 | $23,293 | 47.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 183 | 235 | $41,989 | $21,858 | 52.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 166 | 203 | $21,021 | $8,521 | 40.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $16,144 | $7,789 | 48.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 79 | 104 | $8,165 | $4,827 | 59.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 87 | 104 | $8,861 | $4,698 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $4,746 | $2,455 | 51.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 91 | 324 | $3,420 | $1,940 | 56.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $2,563 | $1,438 | 56.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 22 | $1,936 | $965.12 | 49.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $1,631 | $902.72 | 55.4% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 13 | $1,949 | $887.67 | 45.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 23 | $33.71 | $18.82 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 358 | 516 | $70,306 | $34,880 | 49.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 218 | 258 | $41,835 | $19,089 | 45.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 151 | 183 | $32,808 | $16,743 | 51.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 134 | 176 | $18,348 | $7,222 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 71 | 71 | $11,913 | $5,422 | 45.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 63 | 84 | $6,754 | $3,938 | 58.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 82 | 93 | $7,961 | $3,800 | 47.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 90 | 428 | $4,601 | $2,604 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 14 | $2,690 | $1,373 | 51.0% |
| 69100 | Biopsy of ear | Office | 2022 | 13 | 13 | $1,970 | $988.46 | 50.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $1,763 | $631.10 | 35.8% |
About Dr. Sara Gaspard, M.D
Dr. Sara Gaspard, M.D is a Dermatology healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1023253473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Gaspard, M.D has received a total of $436,969 in payments from pharmaceutical and medical device companies, with $53,846 received in 2024. These payments were reported across 1,063 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($274,437).
As a Medicare-enrolled provider, Gaspard has provided services to 5,370 Medicare beneficiaries, totaling 16,546 services with total Medicare billing of $437,180. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Pasadena, CA
- Active Since 12/12/2008
- Last Updated 09/26/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023253473
Products in Payments
- BOTOX (Biological) $60,477
- KYBELLA (Biological) $22,535
- DUPIXENT (Biological) $1,741
- RHOFADE (Drug) $1,570
- COSENTYX (Biological) $764.19
- SKYRIZI (Biological) $683.24
- RINVOQ (Biological) $570.28
- EUCRISA (Drug) $549.72
- ENSTILAR (Drug) $527.82
- Humira (Biological) $525.26
- ESKATA (Drug) $511.44
- DAXXIFY (Drug) $429.78
- COSENTYX (Drug) $357.69
- TALTZ (Drug) $251.81
- Otezla (Drug) $251.29
- DORYX (Drug) $248.28
- EPIDUO FORTE (Drug) $218.00
- ILUMYA (Biological) $205.75
- OPZELURA (Drug) $163.05
- AMELUZ (Drug) $161.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Pasadena
Christine Hunt, M.d, M.D
Dermatology — Payments: $58,864
Dermatology $58,864
Dr. Manuel Davila, Md, MD
Dermatology — Payments: $33,958
Dermatology $33,958
Dr. Ashkan Ghorbani, Md, MD
Dermatology — Payments: $27,488
Dermatology $27,488
Prof. Wendy Magee, M.d, M.D
Dermatology — Payments: $25,850
Dermatology $25,850
Dr. Mary Garman, Md, MD
Dermatology — Payments: $22,772
Dermatology $22,772
Dr. Heather Butler, Md, MD
Dermatology — Payments: $21,843
Dermatology $21,843